These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2535831)

  • 1. Treatment of advanced and recurrent endometrial carcinoma: correlation of patient response to hormonal and cytotoxic chemotherapy and the response predicted by the subrenal capsule chemosensitivity assay.
    Stratton JA; Mannel RS; Rettenmaier MA; Berman ML; DiSaia PJ
    Gynecol Oncol; 1989 Jan; 32(1):55-9. PubMed ID: 2535831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concordance of combination and single agent chemosensitivity prediction in ovarian carcinoma using the subrenal capsule xenograft assay (SRCA).
    Stratton JA; Rettenmaier MA; Kucera PR; Berman ML; DiSaia PJ
    Gynecol Oncol; 1988 Jul; 30(3):416-21. PubMed ID: 3391423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced or recurrent adenocarcinoma of the endometrium with doxorubicin and cyclophosphamide.
    Campora E; Vidali A; Mammoliti S; Ragni N; Conte PF
    Eur J Gynaecol Oncol; 1990; 11(3):181-3. PubMed ID: 2209636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of sequential cyclical hormonal therapy in endometrial cancer and its correlation with steroid hormone receptor status.
    Ayoub J; Audet-Lapointe P; Méthot Y; Hanley J; Beaulieu R; Chemaly R; Cormier A; Déry JP; Drouin P; Gauthier P
    Gynecol Oncol; 1988 Oct; 31(2):327-37. PubMed ID: 2971597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen therapy in advanced/recurrent endometrial carcinoma.
    Quinn MA; Campbell JJ
    Gynecol Oncol; 1989 Jan; 32(1):1-3. PubMed ID: 2909443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VM-26-vincristine-cisplatin combination chemotherapy in the treatment of primary advanced and recurrent endometrial carcinoma.
    Sorbe B; Wolmesjö E; Frankendal B
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):343-8. PubMed ID: 2915860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of cisplatin, doxorubicin, and cyclophosphamide to treat advanced and recurrent adenocarcinoma of the endometrium.
    Hancock KC; Freedman RS; Edwards CL; Rutledge FN
    Cancer Treat Rep; 1986 Jun; 70(6):789-91. PubMed ID: 3731140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A trial of combination chemotherapy followed by hormonal therapy for previously untreated metastatic carcinoma of the prostate.
    Seifter EJ; Bunn PA; Cohen MH; Makuch RW; Dunnick NR; Javadpour N; Bensimon H; Eddy JL; Minna JD; Ihde DC
    J Clin Oncol; 1986 Sep; 4(9):1365-73. PubMed ID: 2943877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
    Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accurate laboratory predictions of the clinical response of patients with advanced ovarian cancer to treatment with cyclophosphamide, doxorubicin, and cisplatin.
    Stratton JA; Kucera PR; Rettenmaier MA; Dobashi K; Micha JP; Braly PS; Berman ML; DiSaia PJ
    Gynecol Oncol; 1986 Nov; 25(3):302-10. PubMed ID: 3781341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-Platinum, and megestrol acetate.
    Lovecchio JL; Averette HE; Lichtinger M; Townsend PA; Girtanner RW; Fenton AN
    Obstet Gynecol; 1984 Apr; 63(4):557-60. PubMed ID: 6538327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of recurrent or metastatic poorly differentiated adenocarcinoma of the endometrium with tamoxifen and medroxyprogesterone acetate.
    Kline RC; Freedman RS; Jones LA; Atkinson EN
    Cancer Treat Rep; 1987 Mar; 71(3):327-8. PubMed ID: 2949831
    [No Abstract]   [Full Text] [Related]  

  • 13. Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma.
    Piver MS; Lele SB; Marchetti DL; Baker TR; Emrich LJ; Hartman AB
    J Clin Oncol; 1988 Nov; 6(11):1679-84. PubMed ID: 3183700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma.
    Malfetano J; Keys H; Kredentser D; Cunningham M; Kotlove D; Weiss L
    Cancer; 1993 Jun; 71(11):3703-6. PubMed ID: 8387884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy in the management of advanced or recurrent cervical and endometrial carcinoma.
    Thigpen T; Vance RB; Balducci L; Blessing J
    Cancer; 1981 Jul; 48(2 Suppl):658-65. PubMed ID: 7023669
    [No Abstract]   [Full Text] [Related]  

  • 16. Mitotic index in the subrenal capsule assay as an indicator of the chemosensitivity of ovarian cancer.
    Suonio E; Lipponen P; Mäenpää J; Syrjänen K; Kangas L; Tuomisto L
    Cancer Chemother Pharmacol; 1997; 41(1):15-21. PubMed ID: 9443609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
    Burke TW; Stringer CA; Morris M; Freedman RS; Gershenson DM; Kavanagh JJ; Edwards CL
    Gynecol Oncol; 1991 Mar; 40(3):264-7. PubMed ID: 2013451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical assessment of the results of predicting individual sensitivity to adjuvant chemotherapy in lung tumors].
    Sergeeva NS; Skotnikova OI; Chissov VI; Borisov VI; Trakhtenberg AKh; Bil'danova LA; Pelevina II
    Vopr Onkol; 1992; 38(9):1062-5. PubMed ID: 1338676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC).
    Levenback C; Burke TW; Silva E; Morris M; Gershenson DM; Kavanagh JJ; Wharton JT
    Gynecol Oncol; 1992 Sep; 46(3):317-21. PubMed ID: 1526508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of recurrent and metastatic endometrial cancer with cisplatin, doxorubicin, cyclophosphamide, and megestrol acetate.
    Hoffman MS; Roberts WS; Cavanagh D; Praphat H; Solomon P; Lyman GH
    Gynecol Oncol; 1989 Oct; 35(1):75-7. PubMed ID: 2477317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.